His research interests are centered on essential fatty acid-derived Specialized Pro-resolving Mediators (SPM) and their role in host defense and resolution of inflammation. He is an investigator in a NIH-funded program project grant led by Prof Charles Serhan that aims to harness SPMs and the recently discovered bioactive SPM-sulfido conjugates for resolution pharmacology. The over-arching goal is to develop novel therapies to better treat human diseases defined by uncontrolled inflammation and impaired tissue repair, such as diabetes mellitus.